Article: Critical Therapeutics Inc. Enter a Promo Pact With Dey.

M2 PRESSWIRE-14 March 2007-International Stock Targets: Critical Therapeutics Inc. Enter a Promo Pact With Dey(C)1994-2007 M2 COMMUNICATIONS LTD

RDATE:14032007

Critical Therapeutics Inc. (Nasdaq:CRTX) was 24.44% today on just over 1.2 million shares traded.

Drug developer Critical Therapeutics Inc. said Wednesday it signed a co-promotion agreement with Dey LP, an affiliate of German drug maker Merck KGaA, to sell each others' respiratory products.

Financial terms of the agreement were not disclosed.

Under the agreement, the two companies will use a combined sales force of 240 reps to sell Critical Therapeutics' Zyflo asthma ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!